Your browser doesn't support javascript.
loading
Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
Kumar, Amanika; Wang, Chen; Sheedy, Shannon P; McCauley, Bryan M; Winham, Stacey J; Ramus, Susan J; Anglesio, Michael S; Kim, Bohyun; Torres, Diogo; Keeney, Gary L; Cliby, William A; Goode, Ellen L.
Afiliação
  • Kumar A; Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States. Electronic address: Kumar.Amanika@mayo.edu.
  • Wang C; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Sheedy SP; Department of Radiology, Mayo Clinic, Rochester, MN, United States.
  • McCauley BM; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.
  • Winham SJ; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Ramus SJ; School of Clinical Medicine, Faculty of Medicine, University of NSW Sydney, Sydney, New South Wales, Australia; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
  • Anglesio MS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Kim B; Department of Radiology, Mayo Clinic, Rochester, MN, United States.
  • Torres D; Division of Gynecologic Oncology, Ochsner Health Center, New Orleans, LA.
  • Keeney GL; Division of Gynecologic Oncology, Ochsner Health Center, New Orleans, LA.
  • Cliby WA; Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Goode EL; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, United States.
Gynecol Oncol ; 166(3): 508-514, 2022 09.
Article em En | MEDLINE | ID: mdl-35931468
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article